Regulation of Extracellular Matrix Homeostatsis in Skin Aging
皮肤衰老过程中细胞外基质稳态的调节
基本信息
- 批准号:8512628
- 负责人:
- 金额:$ 28.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-08-15 至 2014-07-31
- 项目状态:已结题
- 来源:
- 关键词:Age of OnsetAgingAntioxidantsBehavior ControlBiochemicalBlood VesselsCaringCell Culture TechniquesCell RespirationCellsCollagenCollagen Type IConnective TissueControlled EnvironmentContusionsDataDermalDermisElderlyEpidermisEpitheliumExtracellular MatrixExtracellular Matrix ProteinsFibroblastsFree RadicalsGoalsHair follicle structureHumanImmuneImpairmentMADH3 geneMechanicsMediatingMedicalMolecularNerveNeuronsOrganPathway interactionsPopulationProductionPropertyProteinsPublic HealthReactive Oxygen SpeciesRegulationResearchSebaceous GlandsSignal PathwaySignal TransductionSkiingSkinSkin AgingSmooth Muscle MyocytesStructural ProteinStructureStudy modelsSweat GlandsTestingTimeType I ProcollagenWound Healingage relatedagedappendagebasecell behaviorcell typeconnective tissue growth factorin vivoinsightoxidationtheories
项目摘要
The long-term goal of the proposed research is to understand molecular basis and functional impact of skin
connective tissue aging. Skin, like all human organs, undergoes deleterious alterations as a consequence of
the passage of time. Natural aging of skin is manifested primarily by thinning, largely due to loss of type I
collagen in the dermis. Type I collagen is the most abundant protein in skin and confers structure, strength
and resiliency. Age-dependent loss of collagen causes increased fragility and thereby makes skin more
susceptible to bruising and impedes wound healing. Aging of the US population makes medical care of fragile
skin a growing public health concern. In addition to being the largest human organ, skin is readily accessible
for study. These unique properties of skin provide the opportunity study molecular mechanisms of aging in
humans. The free radical theory of aging posits that natural aging is driven by cellular damage that results
from oxidation by reactive oxygen species (ROS) that are generated as a consequence of aerobic metabolism.
We find that ROS levels are elevated in aged human skin fibroblasts in vivo. Fibroblasts are the major cell
type that produces type I collagen. In addition, we find that the TGF-¿/SMAD/CTGF axis, which is the major
regulatory network that drives type I collagen production in skin, is impaired in aged human skin. This
impairment results from decreased expression of SMAD3, which is a downstream effector of TGF-¿ actions,
and reduced expression of connective tissue growth factor (CTGF), which is a multi-functional protein that acts
in concert with TGF-¿ to regulate type I collagen expression. Furthermore, we find that mild, short-term
oxidative exposure of primary cultured human dermal fibroblasts causes permanent cellular alterations that
closely mimic those observed in fibroblasts in aged skin in vivo; namely, increased ROS, reduced SMAD3,
reduced CTGF, and reduced type I collagen expression. Based on these observations, we hypothesize that
increased ROS, reduces expression of SMAD3 and CTGF, which results in reduction of type I collagen
production, in fibroblasts in aged human skin. We propose four Specific Aims to test this hypothesis: 1)
determine age-related alterations of ROS, SMAD3, CTGF, and type I collagen production, in human skin
fibroblasts in vivo, 2) determine the ability of topical anti-oxidant to reduce ROS levels, mitigate impairment of
the TGF-¿/SMAD/CTGF axis, and induce type I collagen production, in aged human skin in vivo, 3) determine
molecular mechanisms by which oxidative exposure reduces SMAD3, CTGF and type I collagen expression in
human ski fibroblasts, and 4) determine molecular mechanisms by which CTGF regulates type I collagen
expression. The results from the proposed studies will provide important insights regarding 1) the age of onset
of human skin aging, 2) molecular actions of topical antioxidant, 3) mechanisms by which oxidative exposure
regulates the TGF-¿/SMAD/CTGF axis, and 4) molecular basis by which CTGF cooperates with TGF-¿ in the
regulation of type I collagen expression.
拟议研究的长期目标是了解皮肤的分子基础和功能影响
结缔组织老化皮肤,像所有的人体器官一样,经历了有害的变化,
时间的流逝皮肤的自然老化主要表现为变薄,主要是由于I型胶原的丧失。
真皮中的胶原蛋白。I型胶原蛋白是皮肤中最丰富的蛋白质,
和弹性。胶原蛋白的依赖性损失会导致脆性增加,从而使皮肤变得更加脆弱。
容易擦伤并阻碍伤口愈合。美国人口老龄化使医疗保健变得脆弱
皮肤是一个日益增长的公共卫生问题。皮肤是人体最大的器官,
为了学习皮肤的这些独特性质为研究衰老的分子机制提供了机会,
人类衰老的自由基理论认为,自然衰老是由细胞损伤引起的,
由有氧代谢产生的活性氧(ROS)氧化而成。
我们发现,活性氧水平升高,在体内老化的人皮肤成纤维细胞。成纤维细胞是主要的细胞
产生I型胶原蛋白。此外,我们发现,TGF-β/SMAD/CTGF轴,这是主要的
驱动皮肤中I型胶原蛋白产生的调节网络在老年人皮肤中受损。这
损伤由SMAD 3表达减少引起,SMAD 3是TGF-β作用的下游效应物,
结缔组织生长因子(CTGF)的表达减少,CTGF是一种多功能蛋白质,
与TGF-β协同调节I型胶原表达。此外,我们发现,温和,短期
原代培养的人皮肤成纤维细胞的氧化暴露引起永久性细胞改变,
与在体内老化皮肤的成纤维细胞中观察到的那些密切相似;即增加的ROS,减少的SMAD 3,
CTGF减少和I型胶原蛋白表达减少。基于这些观察,我们假设,
ROS增加,SMAD 3和CTGF的表达减少,导致I型胶原减少
在老年人皮肤的成纤维细胞中产生。我们提出了四个具体目标来检验这一假设:1)
确定人皮肤中ROS、SMAD 3、CTGF和I型胶原蛋白产生的年龄相关变化
2)测定局部抗氧化剂降低ROS水平、减轻成纤维细胞损伤的能力,
TGF-β/SMAD/CTGF轴,并诱导I型胶原蛋白产生,3)确定
氧化暴露降低SMAD 3、CTGF和I型胶原表达的分子机制
人滑雪成纤维细胞,以及4)确定CTGF调节I型胶原的分子机制
表情拟议研究的结果将提供关于1)发病年龄的重要见解
2)局部抗氧化剂的分子作用,3)氧化暴露的机制,
调节TGF-β/SMAD/CTGF轴,以及4)CTGF与TGF-β在细胞内协同作用的分子基础。
I型胶原表达的调节。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GARY J FISHER其他文献
GARY J FISHER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GARY J FISHER', 18)}}的其他基金
YAP/TAZ Regulation of Extracellular Matrix Homeostasis
YAP/TAZ 细胞外基质稳态的调节
- 批准号:
10719507 - 财政年份:2023
- 资助金额:
$ 28.48万 - 项目类别:
The impact of the dermal ECM microenvironment on cutaneous aging and cancer
真皮ECM微环境对皮肤衰老和癌症的影响
- 批准号:
10637690 - 财政年份:2023
- 资助金额:
$ 28.48万 - 项目类别:
Impact of age-related changes of the dermal extracellular matrix on skin cancer
真皮细胞外基质与年龄相关的变化对皮肤癌的影响
- 批准号:
9233494 - 财政年份:2017
- 资助金额:
$ 28.48万 - 项目类别:
Control of aging and age-related diseases by extracellular matrix microenvironment
细胞外基质微环境控制衰老和年龄相关疾病
- 批准号:
10163759 - 财政年份:2017
- 资助金额:
$ 28.48万 - 项目类别:
Control of aging and age-related diseases by extracellular matrix microenvironment
细胞外基质微环境控制衰老和年龄相关疾病
- 批准号:
9922195 - 财政年份:2017
- 资助金额:
$ 28.48万 - 项目类别:
Control of aging and age-related diseases by extracellular matrix microenvironment
细胞外基质微环境控制衰老和年龄相关疾病
- 批准号:
10410587 - 财政年份:2017
- 资助金额:
$ 28.48万 - 项目类别:
Control of aging and age-related diseases by extracellular matrix microenvironment
细胞外基质微环境控制衰老和年龄相关疾病
- 批准号:
9523384 - 财政年份:2017
- 资助金额:
$ 28.48万 - 项目类别:
Role of dermal extracellular matrix microenvironment in skin aging
真皮细胞外基质微环境在皮肤衰老中的作用
- 批准号:
9176369 - 财政年份:2016
- 资助金额:
$ 28.48万 - 项目类别:
Role of dermal extracellular matrix microenvironment in skin aging
真皮细胞外基质微环境在皮肤衰老中的作用
- 批准号:
9899818 - 财政年份:2016
- 资助金额:
$ 28.48万 - 项目类别:
Regulation of Extracellular Matrix Homeostatsis in Skin Aging
皮肤衰老过程中细胞外基质稳态的调节
- 批准号:
7907781 - 财政年份:2009
- 资助金额:
$ 28.48万 - 项目类别:
相似海外基金
Potential of Oxyresveratrol and other antioxidants to protect cells from trauma and aging
氧化白藜芦醇和其他抗氧化剂具有保护细胞免受创伤和衰老的潜力
- 批准号:
415301-2011 - 财政年份:2011
- 资助金额:
$ 28.48万 - 项目类别:
University Undergraduate Student Research Awards
Anti-aging effects of novel antioxidants Design, synthesis and testing for chemical and biological activity.
新型抗氧化剂的抗衰老作用化学和生物活性的设计、合成和测试。
- 批准号:
234723-2000 - 财政年份:2002
- 资助金额:
$ 28.48万 - 项目类别:
Strategic Projects - Group
Anti-aging effects of novel antioxidants Design, synthesis and testing for chemical and biological activity.
新型抗氧化剂的抗衰老作用化学和生物活性的设计、合成和测试。
- 批准号:
234723-2000 - 财政年份:2001
- 资助金额:
$ 28.48万 - 项目类别:
Strategic Projects - Group
ANTIOXIDANTS AND REPERFUSION INJURY IN AGING HEART
衰老心脏中的抗氧化剂和再灌注损伤
- 批准号:
6359552 - 财政年份:2000
- 资助金额:
$ 28.48万 - 项目类别:
Anti-aging effects of novel antioxidants Design, synthesis and testing for chemical and biological activity.
新型抗氧化剂的抗衰老作用化学和生物活性的设计、合成和测试。
- 批准号:
234723-2000 - 财政年份:2000
- 资助金额:
$ 28.48万 - 项目类别:
Strategic Projects - Group
ANTIOXIDANTS AND REPERFUSION INJURY IN AGING HEART
衰老心脏中的抗氧化剂和再灌注损伤
- 批准号:
6218772 - 财政年份:1999
- 资助金额:
$ 28.48万 - 项目类别:
ANTIOXIDANTS AND REPERFUSION INJURY IN AGING HEART
衰老心脏中的抗氧化剂和再灌注损伤
- 批准号:
6098816 - 财政年份:1999
- 资助金额:
$ 28.48万 - 项目类别:
ANTIOXIDANTS AND REPERFUSION INJURY IN AGING HEART
衰老心脏中的抗氧化剂和再灌注损伤
- 批准号:
6267774 - 财政年份:1998
- 资助金额:
$ 28.48万 - 项目类别:
Mitochondrial Antioxidants, Aging and Healthspan
线粒体抗氧化剂、衰老和健康寿命
- 批准号:
8816010 - 财政年份:1997
- 资助金额:
$ 28.48万 - 项目类别:
Mitochondrial Antioxidants, Aging and Healthspan
线粒体抗氧化剂、衰老和健康寿命
- 批准号:
8431784 - 财政年份:1997
- 资助金额:
$ 28.48万 - 项目类别:














{{item.name}}会员




